{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T06:45:54Z","timestamp":1766040354846,"version":"3.48.0"},"reference-count":28,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T00:00:00Z","timestamp":1766016000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000050","name":"NHLBI","doi-asserted-by":"publisher","award":["R01 HL164016-01A1"],"award-info":[{"award-number":["R01 HL164016-01A1"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Lymphocytic variant hypereosinophilic syndrome (L-HES) is a rare subtype of hypereosinophilic syndrome driven by aberrant T-cell clones that promote eosinophilia through interleukin-5 (IL-5) overproduction. While clonal T-cell receptor (TCR) rearrangements are a hallmark, the underlying genetic landscape remains poorly defined.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We report a familial case series involving five siblings, three symptomatic and two asymptomatic, with comprehensive clinical, immunophenotypic, and genomic evaluations. Whole-exome sequencing (WES) was performed to identify rare germline variants contributing to disease susceptibility. The index patient (EOS1) presented with clonal CD3\n                      <jats:sup>\u2212<\/jats:sup>\n                      CD4\n                      <jats:sup>+<\/jats:sup>\n                      T cells, marked eosinophilia, and papillary thyroid carcinoma (PTC). Flow cytometry, TCR gene rearrangement studies, and a targeted 141-gene NGS panel were conducted, followed by whole-exome variant calling and annotation.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>EOS1 exhibited classic L-HES features and a positive TCR clonality test. Exome analysis revealed several nonsynonymous variants of uncertain significance in genes related to transcriptional regulation (ZNF257, MLLT1, BRD9), immune signaling (TESPA1, LRCH4, DHX58), and oncogenesis (CTAGE4, RGPD5). No STAT3 or recurrent mutations were identified. Several variants were shared among affected siblings but absent in unaffected controls, suggesting a possible hereditary predisposition.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>This study highlights novel germline variants potentially associated with L-HES pathogenesis and expands the genomic spectrum beyond previously implicated somatic mutations. Our findings support the role of immune dysregulation and genetic predisposition in L-HES and underscore the importance of broader genomic profiling in familial cases. Functional validation and long-term monitoring are essential for risk stratification and early detection of malignant transformation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fmed.2025.1679484","type":"journal-article","created":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T06:42:22Z","timestamp":1766040142000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Genetic mutations in lymphocytic variant of hypereosinophilic syndrome: study of five siblings"],"prefix":"10.3389","volume":"12","author":[{"given":"Molly","family":"Walkenhorst","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Malay K.","family":"Basu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Cui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manish","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anusha","family":"Vallurupalli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Sitek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinyang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"X. Long","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Da","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,12,18]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.jaci.2012.02.019","article-title":"Contemporary consensus proposal on criteria and classification of eosinophilic disorders and related syndromes","volume":"130","author":"Valent","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1586\/ehm.11.81","article-title":"Pathogenesis and classification of eosinophil disorders: a review of recent developments in the field","volume":"5","author":"Valent","year":"2012","journal-title":"Expert Rev Hematol"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.iac.2012.04.002","article-title":"Lymphocytic variant hypereosinophilic syndrome","volume":"32","author":"Cogan","year":"2012","journal-title":"Immunol Allergy Clin N Am"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1002\/cyto.b.21874","article-title":"Lymphocytic variant of hypereosinophilic syndrome: a report of seven cases from a single institution","volume":"100","author":"Hu","year":"2021","journal-title":"Cytometry B"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1182\/blood-2015-06-654277","article-title":"Identification of a gain-of-function STAT3 mutation (p.Y640F) in lymphocytic variant hypereosinophilic syndrome","volume":"127","author":"Walker","year":"2016","journal-title":"Blood"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"486","DOI":"10.3390\/ijms22020486","article-title":"Molecular pathogenesis and treatment perspectives for hypereosinophilia and hypereosinophilic syndromes","volume":"22","author":"Stella","year":"2021","journal-title":"Int J Mol Sci"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"1992","DOI":"10.3390\/cells9091992","article-title":"Gene expression comparison between S\u00e9zary syndrome and lymphocytic-variant hypereosinophilic syndrome refines biomarkers for S\u00e9zary syndrome","volume":"9","author":"Moerman-Herzog","year":"2020","journal-title":"Cells"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1055\/s-0040-1719030","article-title":"Exome sequencing identifies abnormalities in glycosylation and ANKRD36C in patients with immune-mediated thrombotic thrombocytopenic purpura","volume":"121","author":"Basu","year":"2021","journal-title":"Thromb Haemost"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1093\/bioinformatics\/btu170","article-title":"Trimmomatic: a flexible trimmer for Illumina sequence data","volume":"30","author":"Bolger","year":"2014","journal-title":"Bioinformatics"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"e164","DOI":"10.1093\/nar\/gkq603","article-title":"ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data","volume":"38","author":"Wang","year":"2010","journal-title":"Nucleic Acids Res"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"142182","DOI":"10.1016\/j.ijbiomac.2025.142182","article-title":"Codon usage bias and nucleotide bias are not influenced by the 5\u2032 flanking but by 3\u2032 and intronic region composition in SCID-associated genes","volume":"308","author":"Zou","year":"2025","journal-title":"Int J Biol Macromol"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1038\/s41467-020-15220-0","article-title":"Dissecting the early steps of MLL induced leukaemogenic transformation using a mouse model of AML","volume":"11","author":"Basilico","year":"2020","journal-title":"Nat Commun"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"8372","DOI":"10.1038\/s41467-023-44081-6","article-title":"BRD9 determines the cell fate of hematopoietic stem cells by regulating chromatin state","volume":"14","author":"Xiao","year":"2023","journal-title":"Nat Commun"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1210\/me.2011-1242","article-title":"TACC2 is an androgen-responsive cell cycle regulator promoting androgen-mediated and castration-resistant growth of prostate cancer","volume":"26","author":"Takayama","year":"2012","journal-title":"Mol Endocrinol"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"110539","DOI":"10.1016\/j.ygeno.2022.110539","article-title":"FRG1 is a direct transcriptional regulator of nonsense-mediated mRNA decay genes","volume":"115","author":"Palo","year":"2023","journal-title":"Genomics"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.1074\/jbc.RA118.004300","article-title":"Leucine-rich repeats and calponin homology containing 4 (Lrch4) regulates the innate immune response","volume":"294","author":"Aloor","year":"2019","journal-title":"J Biol Chem"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"4772","DOI":"10.1038\/s41467-024-48663-w","article-title":"Retrotransposons in Werner syndrome-derived macrophages trigger type I interferon-dependent inflammation in an atherosclerosis model","volume":"15","author":"Paul","year":"2024","journal-title":"Nat Commun"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"26496","DOI":"10.18632\/oncotarget.8420","article-title":"Cancer therapies activate RIG-I-like receptor pathway through endogenous non-coding RNAs","volume":"7","author":"Ranoa","year":"2016","journal-title":"Oncotarget"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s12929-024-01034-5","article-title":"Characterization of the genetic variation and evolutionary divergence of the CLEC18 family","volume":"31","author":"Chang","year":"2024","journal-title":"J Biomed Sci"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1093\/ced\/llad297","article-title":"Expression of hornerin in skin lesions of atopic dermatitis and skin diseases","volume":"49","author":"Makino","year":"2024","journal-title":"Clin Exp Dermatol"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"2519","DOI":"10.1002\/1873-3468.14749","article-title":"RANBP2 evolution and human disease","volume":"597","author":"Desgraupes","year":"2023","journal-title":"FEBS Lett"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1038\/s10038-019-0691-4","article-title":"Further evidence of involvement of TMEM132E in autosomal recessive nonsyndromic hearing impairment","volume":"65","author":"Liaqat","year":"2020","journal-title":"J Hum Genet"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"10011","DOI":"10.35534\/jrbtm.2024.10011","article-title":"Solute carrier family 26 member 4 (SLC26A4), a potential therapeutic target for asthma","volume":"1","author":"Guntupalli","year":"2024","journal-title":"J Respir Biol Transl Med"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1089\/thy.2010.1641","article-title":"Familial syndromes associated with thyroid cancer in the era of personalized medicine","volume":"20","author":"Richards","year":"2010","journal-title":"Thyroid"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"72","DOI":"10.5483\/BMBRep.2022.55.2.010","article-title":"Odorant receptors in cancer","volume":"55","author":"Chung","year":"2022","journal-title":"BMB Rep"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"3136","DOI":"10.3390\/diagnostics12123136","article-title":"Molecular landscape of pediatric thyroid cancer: a review","volume":"12","author":"Guleria","year":"2022","journal-title":"Diagnostics"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/j.cell.2014.09.050","article-title":"Integrated genomic characterization of papillary thyroid carcinoma","volume":"159","year":"2014","journal-title":"Cell"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"3146","DOI":"10.3390\/cancers12113146","article-title":"Genetic landscape of papillary thyroid carcinoma and nuclear architecture: an overview comparing pediatric and adult populations","volume":"12","author":"Rangel-Pozzo","year":"2020","journal-title":"Cancers"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1679484\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T06:42:28Z","timestamp":1766040148000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1679484\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,18]]},"references-count":28,"alternative-id":["10.3389\/fmed.2025.1679484"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2025.1679484","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,18]]},"article-number":"1679484"}}